Display Options:
Total: 968
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell
CD70 antigen cross-linking agent
Antibody
Investigational
Unknown
Unknown
Unknown
Interleukin-1 beta inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders
Transferrin receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Dengue; Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome
Monocyte differentiation antigen CD14 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
TNF-beta inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Blood group Rh(D) polypeptide inhibitor
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease
Microtubule-associated protein tau inhibitor
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Lung Neoplasms; Mesothelioma; Neoplasms; Pancreatic Neoplasms
Mesothelin binding agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Pancreatic Neoplasms
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Amyloidosis
Serum amyloid P-component inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms
Mucin-1 other
Antibody
Investigational
Unknown
Unknown
Lymphoma; Hematologic Neoplasms; Hodgkin Disease
Tumor necrosis factor receptor superfamily member 8 other
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms
DNA inhibitor
Antibody
Investigational
Unknown
Unknown
Anemia; Renal Insufficiency, Chronic
Interleukin-6 binding agent
Antibody
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal; Asthma; Urticaria
Ig epsilon chain C region inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Oxidized LDL inhibitor
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Neoplasms; Psoriasis; Lupus Erythematosus, Systemic
T-cell-specific surface glycoprotein CD28 agonist
Antibody
Investigational
Unknown
Unknown
Unknown
B-lymphocyte antigen CD19 binding agent
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease; Supranuclear Palsy, Progressive
Microtubule-associated protein tau inhibitor
Antibody
Investigational
Unknown
Unknown
Influenza, Human
Hemagglutinin inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Major surface antigen inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma; Prostatic Neoplasms
Integrin alpha-V/beta-3 antagonist
Antibody
Investigational
Unknown
Unknown
Lymphoma; Breast Neoplasms; Melanoma
Programmed cell death 1 ligand 1 binding agent
Antibody
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Peanut Hypersensitivity; Sinusitis
Interleukin-33 binding agent
Antibody
Investigational
Unknown
Unknown
HIV Infections; Acquired Immunodeficiency Syndrome
Envelope glycoprotein gp160 inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Tenascin binding agent
Antibody
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Optic Neuritis
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown